Similar articles

• Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists.

  Ringdahl B, Dahlbom R. Ringdahl B, et al. Acta Pharm Suec. 1979;16(1):13-20. Acta Pharm Suec. 1979. PMID: 452907 No abstract available.
• Acetylene compounds of potential pharmacological value. XXII. Base strength and biological activity in oxotremorine antagonists.

  Svensson U, Ringdahl B, Dahlbom R. Svensson U, et al. Acta Pharm Suec. 1975;12(5-6):393-400. Acta Pharm Suec. 1975. PMID: 1217491 No abstract available.
• Acetylene compounds of potential pharmacological value. XXXVI. N-(4-tert-Amino-2-butynyl)-substituted 2(3H)-thiazolones and 2(3H)-oxazolones.

  Moses P, Dahlbom R. Moses P, et al. Acta Pharm Suec. 1978;15(3):175-80. Acta Pharm Suec. 1978. PMID: 716951 No abstract available.
• Acetylene compounds of potential pharmacological value. XXI. Further studies on the effect of branching the intermediate chain of N-(t-aminoalkynyl)-substituted succinimides and 2-pyrrolidones.

  Ringdahl B, Svensson U, Dahlbom R. Ringdahl B, et al. Acta Pharm Suec. 1975;12(4):297-304. Acta Pharm Suec. 1975. PMID: 1199731 No abstract available.
• Acetylene compounds of potential pharmacological value. XXIII. N-(1-Methyl-5-pyrrolidino-3-pentynyl)-substituted succinimide and 2-pyrrolidone.

  Lindgren S, Svensson U, Dahlbom R. Lindgren S, et al. Acta Pharm Suec. 1975;12(5-6):503-6. Acta Pharm Suec. 1975. PMID: 1217504 No abstract available.